Overview of Microgestin 1/20
Microgestin 1/20, identified by the National Drug Code (NDC) 51862-0868, is a combination oral contraceptive manufactured by Mayne Pharma Inc. This medication is designed to prevent pregnancy and is composed of norethindrone acetate and ethinyl estradiol.
Market Context
Pharmaceutical Market Trends
The pharmaceutical market is undergoing significant changes, driven by advancements in technology, regulatory shifts, and evolving patient needs. For 2025, several key trends are expected to influence the market:
-
Gene Therapy and Advanced Treatments: The approval of high-cost gene therapies highlights the need for sustainable financial models in healthcare. This trend may impact the pricing and accessibility of other medications, including contraceptives like Microgestin 1/20[4].
-
AI and Health Tech: The increasing adoption of artificial intelligence (AI) in pharmaceutical operations, including drug discovery and clinical trials, could streamline the development and approval process for new medications. However, this may not directly impact the pricing of existing drugs like Microgestin 1/20 in the short term[3].
Pharmacy Market Outlook
The Vizient Pharmacy Market Outlook for 2025 projects a stable overall drug price inflation rate of 0.00% for the period from January 1, 2025, to December 31, 2025. This suggests that the prices of many pharmaceuticals, including contraceptives, may remain relatively stable[4].
Pricing and Cost Analysis
Current Pricing
The average pharmacy cost for Microgestin 1/20 can vary based on several factors, including the pharmacy, location, and insurance coverage. As of recent data, specific wholesale prices for NDC 51862-0868 are not publicly disclosed, but general trends in pharmacy costs can provide some insight.
Price Projections
Given the stable overall drug price inflation rate projected for 2025, it is likely that the price of Microgestin 1/20 will not see significant increases. Here are some key points to consider:
-
Stable Inflation Rate: With a projected 0.00% overall drug price inflation rate, the cost of Microgestin 1/20 is expected to remain relatively stable throughout 2025[4].
-
Market Competition: The contraceptive market is competitive, which can help keep prices in check. Manufacturers like Mayne Pharma must balance pricing with market demand and competition from other contraceptive products.
-
Regulatory Environment: Any changes in regulatory policies or reimbursement models could impact the pricing of pharmaceuticals. However, as of the current outlook, no significant regulatory changes are anticipated that would specifically affect the pricing of Microgestin 1/20.
Supply and Demand
Manufacturer and Distribution
Mayne Pharma Inc., the manufacturer of Microgestin 1/20, has a robust distribution network. The company's compliance with FDA regulations and its history of maintaining product availability suggest that supply chain disruptions are unlikely to significantly impact the price of this medication[1].
Patient Demand
The demand for oral contraceptives remains steady, driven by the need for effective birth control methods. Any fluctuations in demand are more likely to be influenced by changes in patient preferences or the introduction of new contraceptive options rather than by price changes alone.
Conclusion
Key Takeaways
- Stable Pricing: The price of Microgestin 1/20 is expected to remain stable in 2025, aligned with the overall 0.00% drug price inflation rate.
- Market Trends: Advancements in AI and health tech, as well as the rise of gene therapies, are shaping the pharmaceutical market but are not anticipated to directly impact the pricing of existing contraceptives.
- Supply and Demand: The supply chain for Microgestin 1/20 is robust, and demand for oral contraceptives is steady, which supports stable pricing.
FAQs
What is the NDC for Microgestin 1/20?
The NDC for Microgestin 1/20 is 51862-0868.
Who manufactures Microgestin 1/20?
Microgestin 1/20 is manufactured by Mayne Pharma Inc.
What are the projected price trends for pharmaceuticals in 2025?
The overall drug price inflation rate for 2025 is projected to be 0.00%, indicating stable prices for most pharmaceuticals, including Microgestin 1/20[4].
How does AI impact the pharmaceutical market?
AI is expected to play a larger role in pharmaceutical operations, including drug discovery and clinical trials, but its immediate impact on the pricing of existing drugs like Microgestin 1/20 is minimal[3].
What factors influence the price of Microgestin 1/20?
The price of Microgestin 1/20 is influenced by market competition, regulatory environment, and overall drug price inflation rates.
Sources
- FindACode: Mayne Pharma - List of Drugs - NDC Labeler/Manufacturer.
- DrugPatentWatch: Drug Price Trends for NDC 51862-0186.
- Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
- Vizient Inc.: Pharmacy Market Outlook Summer 2024.
- FDA: National Drug Code Database Background Information.
Last updated: 2025-01-01
